4.7 Article

Quantifying technical confounders in microbiome studies

Journal

CARDIOVASCULAR RESEARCH
Volume 117, Issue 3, Pages 863-875

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/cvr/cvaa128

Keywords

Microbiome; Microbiota; DNA extraction; 16S sequencing; Confounders

Funding

  1. German Research Foundation (DFG) [CRC1365]
  2. Berlin Institute of Health (BIH) - Corona Foundation (Corona-Stiftung im deutschen Stiftungsverband)
  3. European Research Council (ERC) under the European Union [852796]
  4. European Research Council (ERC) [852796] Funding Source: European Research Council (ERC)

Ask authors/readers for more resources

DNA extraction methods have a significant impact on the variability of observed microbiome, comparable to interindividual differences, potentially mimicking microbiome signatures of health and nutrition factors. Collection methods have a relatively small influence on microbiome composition. This study provides insight into technical variables to standardize microbiome quantification procedures in clinical research.
Aims Recent technical developments have allowed the study of the human microbiome to accelerate at an unprecedented pace. Methodological differences may have considerable impact on the results obtained. Thus, we investigated how different storage, isolation, and DNA extraction methods can influence the characterization of the intestinal microbiome, compared to the impact of true biological signals such as intraindividual variability, nutrition, health, and demographics. Methods and results An observative cohort study in 27 healthy subjects was performed. Participants were instructed to collect stool result samples twice spaced by a week, using six different methods (naive and Zymo DNA/RNA Shield on dry ice, OMNIgene GUT, RNALater, 95% ethanol, Zymo DNA/RNA Shield at room temperature). DNA extraction from all samples was performed comparatively using QIAamp Power Fecal and ZymoBIOMICS DNA Kits. 16S rRNA sequencing of the gut microbiota as well as qPCRs were performed on the isolated DNA. Metrics included alpha diversity as well as multivariate and univariate comparisons of samples, controlling for covariate patterns computationally. Interindividual differences explained 7.4% of overall microbiome variability, whereas the choice of DNA extraction method explained a further 5.7%. At phylum level, the tested kits differed in their recovery of Gram-positive bacteria, which is reflected in a significantly skewed enterotype distribution. Conclusion DNA extraction methods had the highest impact on observed microbiome variability, and were comparable to interindividual differences, thus may spuriously mimic the microbiome signatures of various health and nutrition factors. Conversely, collection methods had a relatively small influence on microbiome composition. The present study provides necessary insight into the technical variables which can lead to divergent results from seemingly similar study designs. We anticipate that these results will contribute to future efforts towards standardization of microbiome quantification procedures in clinical research.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cardiac & Cardiovascular Systems

Quantifying the impact of gut microbiota on inflammation and hypertensive organ damage

Ellen G. Avery, Hendrik Bartolomaeus, Ariana Rauch, Chia-Yu Chen, Gabriele N'Diaye, Ulrike Loeber, Theda U. P. Bartolomaeus, Raphaela Fritsche-Guenther, Andre F. Rodrigues, Alex Yarritu, Cheng Zhong, Lingyan Fei, Dmitry Tsvetkov, Mihail Todiras, Joon-Keun Park, Lajos Marko, Andras Maifeld, Andreas Patzak, Michael Bader, Stefan Kempa, Jennifer A. Kirwan, Sofia K. Forslund, Dominik N. Mueller, Nicola Wilck

Summary: This study investigated the impact of microbial colonization on organ damage in hypertension using germ-free and colonized mice models. The results showed that the kidney is more sensitive to microbial influence, and the colonization status is associated with circulating metabolites and inflammatory cells relevant to hypertension.

CARDIOVASCULAR RESEARCH (2023)

Review Cardiac & Cardiovascular Systems

The effect of probiotic and synbiotic supplementation on lipid parameters among patients with cardiometabolic risk factors: a systematic review and meta-analysis of clinical trials

Zeinab Ghorbani, Asma Kazemi, Theda U. P. Bartolomaeus, Fahimeh Martami, Morvarid Noormohammadi, Arsalan Salari, Ulrike Loeber, Heydar Ali Balou, Sofia K. Forslund, Marjan Mahdavi-Roshan

Summary: This study conducted a systematic literature search and meta-analysis to determine the effect sizes of probiotics on blood lipid parameters. The results showed that probiotic/synbiotic supplements can significantly decrease triglyceride, total cholesterol, and LDL-C levels, and increase HDL-C levels. These effects are more pronounced in individuals with hyperlipidemia, diabetes, and metabolic syndrome. However, further large and well-conducted randomized controlled trials are needed to provide more convincing evidence.

CARDIOVASCULAR RESEARCH (2023)

Review Pharmacology & Pharmacy

The effect of probiotic and synbiotic supplementation on appetite-regulating hormones and desire to eat: A systematic review and meta-analysis of clinical trials

Morvarid Noormohammadi, Zeinab Ghorbani, Ulrike Lober, Marjan Mahdavi-Roshan, Theda U. P. Bartolomaeus, Asma Kazemi, Nargeskhatoon Shoaibinobarian, Sofia K. Forslund

Summary: Recent studies have shown that probiotics, prebiotics, and synbiotics can affect the levels of adiponectin and leptin, although these findings are still being debated. This study conducted a systematic review and meta-analysis of randomized controlled trials to explore the impact of probiotic/synbiotic supplementation on appetite-regulating hormones and the desire to eat. The results showed that probiotic/synbiotic supplementation led to a significant decrease in leptin concentration and a slight increase in adiponectin levels, while also slightly increasing the desire to eat.

PHARMACOLOGICAL RESEARCH (2023)

Article Genetics & Heredity

The gut microbiota in multiple sclerosis varies with disease activity

Florence Thirion, Finn Sellebjerg, Yong Fan, Liwei Lyu, Tue H. Hansen, Nicolas Pons, Florence Levenez, Benoit Quinquis, Evelina Stankevic, Helle B. Sondergaard, Thomas M. Dantoft, Casper S. Poulsen, Sofia K. Forslund, Henrik Vestergaard, Torben Hansen, Susanne Brix, Annette Oturai, Per Soelberg Sorensen, Stanislav D. Ehrlich, Oluf Pedersen

Summary: This study found significant differences in the gut microbiota of patients with multiple sclerosis, which are directly associated with inflammation markers. In treatment-naive cases, the bacterial richness is positively linked to disease activity. However, two symbiotic bacterial species that produce beneficial immune-modulating compounds were found in non-disease-active cases, providing a rationale for testing these bacteria as adjunct therapeutics in future clinical trials.

GENOME MEDICINE (2023)

Article Geriatrics & Gerontology

Frailty is characterized by biomarker patterns reflecting inflammation or muscle catabolism in multi-morbid patients

Bastian Kochlik, Kristina Franz, Thorsten Henning, Daniela Weber, Andreas Wernitz, Catrin Herpich, Franziska Jannasch, Volkan Aykac, Ursula Mueller-Werdan, Matthias B. Schulze, Tilman Grune, Kristina Norman

Summary: This study found that specific biomarker patterns, including nutrients, oxidative stress, inflammation biomarkers, and muscle-related biomarkers, are associated with frailty among multi-morbid patients. These biomarker patterns provide more informative results than analyzing single biomarkers.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2023)

Review Immunology

Airway microbiome-immune crosstalk in chronic obstructive pulmonary disease

Alex Kayongo, Nicole M. Robertson, Trishul Siddharthan, Moses Levi Ntayi, Josephine Caren Ndawula, Obondo J. Sande, Bernard S. Bagaya, Bruce Kirenga, Harriet Mayanja-Kizza, Moses L. Joloba, Sofia K. Forslund

Summary: Chronic Obstructive Pulmonary Disease (COPD) is a major contributor to global mortality, with three million deaths reported annually. The impact is expected to increase, with approximately five million people predicted to die from COPD-related causes each year in the next 40 years. The immune mechanisms driving disease progression, as well as the relationship between airway microbiome changes and immune activation, remain unclear.

FRONTIERS IN IMMUNOLOGY (2023)

Article Cell Biology

Sodium perturbs mitochondrial respiration and induces dysfunctional Tregs

Beatriz F. Corte-Real, Ibrahim Hamad, Rebeca Arroyo Hornero, Sabrina Geisberger, Joris Roels, Lauren Van Zeebroeck, Aleksandra Dyczko, Marike W. van Gisbergen, Henry Kurniawan, Allon Wagner, Nir Yoset, Susanne N. Y. Weiss, Klaus G. Schmetterer, Agnes Schroeder, Luka Krampert, Stefanie Haase, Hendrik Bartolomaeus, Niels Hellings, Yvan Saeys, Ludwig J. Dubois, Dirk Brenner, Stefan Kempa, David A. Hafler, Johannes Stegbauer, Ralf A. Linker, Jonathan Jantsch, Dominik N. Mueller, Markus Kleinewietfeld

Summary: High salt induces metabolic reprogramming in human Tregs, leading to pro-inflammatory features and FOXP3 downregulation, which has important implications for autoimmunity.

CELL METABOLISM (2023)

Article Physiology

The Berlin-Buch respiration chamber for energy expenditure measurements

Anja Maehler, Till Schuette, Jochen Steiniger, Michael Boschmann

Summary: This study presents a methodological overview of a respiration chamber at the Experimental and Clinical Research Center in Berlin, Germany. They have investigated 750 healthy subjects and patients with various diseases since 2010. The chamber is able to measure resting energy expenditure, dietary-induced thermogenesis, and activity energy expenditure.

EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY (2023)

Article Urology & Nephrology

Trends and perspectives for improving quality of chronic kidney disease care: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Kai -Uwe Eckardt, Cynthia Delgado, Hiddo J. L. Heerspink, Roberto Pecoits-Filho, Ana C. Ricardo, Benedicte Stengel, Marcello Tonelli, Michael Cheung, Michel Jadoul, Wolfgang C. Winkelmayer, Holly Kramer

Summary: Chronic kidney disease affects a large number of people globally, calling for urgent prevention and management. New tools and interventions, such as biomarkers and artificial intelligence techniques, have emerged to improve the quality and precision of care for CKD. The 2022 KDIGO Controversies Conference discussed best practices and identified knowledge gaps in CKD diagnosis, treatment, and care delivery.

KIDNEY INTERNATIONAL (2023)

Article Medicine, General & Internal

Gut microbiome and atrial fibrillation-results from a large population-based study

Joonatan Palmu, Christin S. Boerschel, Alfredo Ortega-Alonso, Lajos Marko, Michael Inouye, Pekka Jousilahti, Rodolfo A. Salido, Karenina Sanders, Caitriona Brennan, Gregory C. Humphrey, Jon G. Sanders, Friederike Gutmann, Dominik Linz, Veikko Salomaa, Aki S. Havulinna, Sofia K. Forslund, Rob Knight, Leo Lahti, Teemu Niiranen, Renate B. Schnabel

Summary: This study found that the gut microbiome composition is associated with the risk of atrial fibrillation (AF). Certain microbial genera were found to be related to the occurrence and prediction of AF. These findings establish the basis for using microbiome profiling in predicting AF risk, but further research is needed before microbiome sequencing can be used in prevention and targeted treatment of AF.

EBIOMEDICINE (2023)

Article Microbiology

Sputum Microbiome and Chronic Obstructive Pulmonary Disease in a Rural Ugandan Cohort of Well-Controlled HIV Infection

Alex Kayongo, Theda Ulrike Patricia Bartolomaeus, Till Birkner, Lajos Marko, Ulrike Loeber, Edgar Kigozi, Carolyne Atugonza, Richard Munana, Denis Mawanda, Rogers Sekibira, Esther Uwimaana, Patricia Alupo, Robert Kalyesubula, Felix Knauf, Trishul Siddharthan, Bernard S. Bagaya, David P. Kateete, Moses L. Joloba, Nelson K. Sewankambo, Daudi Jjingo, Bruce Kirenga, William Checkley, Sofia K. Forslund

Summary: Even with ART available, HIV-infected individuals are still at high risk of noninfectious lung diseases. Recent studies suggest a link between respiratory microbiota and chronic lung inflammation. This study investigates the microbiome patterns and associations among people living with HIV (PLWH) and COPD in Sub-Saharan Africa. The results reveal significant alterations in the respiratory microbiota among PLWH, indicating the potential of using the sputum microbiome for COPD prognostic and risk stratification strategies.

MICROBIOLOGY SPECTRUM (2023)

Article Neurosciences

Alteration of Gut Microbiome in Patients With Schizophrenia Indicates Links Between Bacterial Tyrosine Biosynthesis and Cognitive Dysfunction

Florence Thirion, Helene Speyer, Tue Haldor Hansen, Trine Nielsen, Yong Fan, Emmanuelle Le Chatelier, Sebastien Fromentin, Magali Berland, Florian Plaza Onate, Nicolas Pons, Nathalie Galleron, Florence Levenez, Lajos Marko, Till Birkner, Torben Jorgensen, Sofia K. Forslund, Henrik Vestergaard, Torben Hansen, Merete Nordentoft, Ole Mors, Michael E. Benros, Oluf Pedersen, Stanislav D. Ehrlich

Summary: This study found significant differences in the gut microbiota between patients with schizophrenia, healthy individuals, and individuals with metabolic syndrome. The functional potential of the gut microbiota was associated with cognitive function in patients with schizophrenia, suggesting the gut microbiota could be a target for intervention to alleviate cognitive dysfunction.

BIOLOGICAL PSYCHIATRY: GLOBAL OPEN SCIENCE (2023)

No Data Available